Recce Pharmaceuticals Ltd (ASX:RCE)

Recce Pharmaceuticals Revenue

In the fiscal year ending June 30, 2026, Recce Pharmaceuticals had annual revenue of 9.94M AUD with 32.36% growth. Recce Pharmaceuticals had revenue of 412.04K in the half year ending December 31, 2025, a decrease of -82.70%.

• Revenue: 9.94M
• Revenue Growth: +29.00%
• P/S Ratio: 10.85
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 107.81M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	9.94M	2.43M	32.36%
Jun 30, 2025	7.51M	2.48M	49.33%
Jun 30, 2024	5.03M	663.14K	15.19%
Jun 30, 2023	4.37M	1.28M	41.50%
Jun 30, 2022	3.08M	1.45M	88.41%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 2, 2026

Data Sources Report a data error